Skip to main content

Table 1 Clinical characteristics of recruited patients

From: CTNNB1 mutations, TERT polymorphism and CD8+ cell densities in resected hepatocellular carcinoma are associated with longer time to recurrence

Variable

n (%)

Gender (n = 67)

 Male

51 (76.1%)

 Female

16 (23.9%)

Disease background(n = 67)

 Cirrhosis

14 (20.9%)

 Hepatitis C

3 (4.5%)

 Alcoholic steatohepatitis

7 (10.4%)

 Cryptogenic chronic hepatitis

7 (10.4%)

 Mixed etiology of hepatitis

9 (13.4%)

 NAFLD/NASH

2 (3.0%)/15 (22.4%)

 Unknown

10 (14.9%)

Tumor Size (n = 67)

 < 5 cm

27 (40.3%)

 > 5 cm

34 (50.7%)

 Unknown

4 (6.0%)

Tumor Number (n = 67)

 Solitary

56 (83.6%)

 Multiple

8 (11.9%)

 Unknown

3 (4.5%)

Tumor Stage (n = 67)

 I

45 (67.2%)

 II

14 (20.9%)

 III

5 (7.5%)

 IV

3 (4.5%)

Event (n = 67)

 Recurrence

29 (43.3%)

 Death

38 (56.7%)